Related references
Note: Only part of the references are listed.Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review
Adrian M. J. Pokorny et al.
BRITISH JOURNAL OF CANCER (2022)
Trends in drug revenue among major pharmaceutical companies: A 2010-2019 cohort study
Daniel E. Meyers et al.
CANCER (2022)
Australian Cancer Physicians and the Pharmaceutical Industry: A Survey of Attitudes and Interactions
Adrian M. J. Pokorny et al.
JCO ONCOLOGY PRACTICE (2022)
Role of Immunotherapy in the Treatment of Cancer: A Systematic Review
Sia Pei Ling et al.
CANCERS (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval
Mahnum Shahzad et al.
JAMA INTERNAL MEDICINE (2021)
Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review
Melissa Mialon et al.
BMJ OPEN (2020)
Early Access Provision for Innovative Medicinal Products in Oncology: Challenges and Opportunities
Andriy Krendyukov
FRONTIERS IN ONCOLOGY (2020)
Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology
Aaron P. Mitchell et al.
ONCOLOGIST (2019)
Asset exchange-interactions between patient groups and pharmaceutical industry: Australian qualitative study
Lisa Parker et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Using Zoom Videoconferencing for Qualitative Data Collection: Perceptions and Experiences of Researchers and Participants
Mandy M. Archibald et al.
INTERNATIONAL JOURNAL OF QUALITATIVE METHODS (2019)
Reconciling a pleasant exchange with evidence of information bias: A three-country study on pharmaceutical sales visits in primary care
Ellen Reynolds et al.
HEALTH POLICY (2018)
Impact of industry collaboration on randomised controlled trials in oncology
Anne Linker et al.
EUROPEAN JOURNAL OF CANCER (2017)
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
Courtney Davis et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
Courtney Davis et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Chronological Changes in Japanese Physicians' Attitude and Behavior Concerning Relationships with Pharmaceutical Representatives: A Qualitative Study
Sayaka Saito et al.
PLOS ONE (2014)
Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review
Lina Alkhaled et al.
BMJ OPEN (2014)
Physicians under the Influence: Social Psychology and Industry Marketing Strategies
Sunita Sah et al.
JOURNAL OF LAW MEDICINE & ETHICS (2013)
Limiting the Influence of Pharmaceutical Industry Gifts on Physicians: Self-Regulation or Government Intervention?
David Grande
JOURNAL OF GENERAL INTERNAL MEDICINE (2010)
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups
Allison Tong et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2007)
Grounded theory: An exploration of process and procedure
D Walker et al.
QUALITATIVE HEALTH RESEARCH (2006)
Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia
E Doran et al.
SOCIAL SCIENCE & MEDICINE (2006)
The bystander effect: A lens for understanding patterns of participation
JM Hudson et al.
JOURNAL OF THE LEARNING SCIENCES (2004)
Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry
PA Komesaroff et al.
MEDICAL JOURNAL OF AUSTRALIA (2002)
Share Paper
